In pancreatic cancer, BRD4770 induced senescent phenotype and activated the ATM (ataxia telangiectasia mutated) pathway to induce DNA damage without affecting ATR (ATM- and Rad3-related) pathway, which ultimately restrained the cell growth [16]. Here, ATM is linked to familial pancreatic carcinoma.